PMC:7784830 / 23299-23669 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784830","sourcedb":"PMC","sourceid":"7784830","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784830","text":"Inovio Pharmaceuticals INO-4800 – vaccine that is developed in collaboration with Beijing Advaccinee Biotechnology Company. It is proposing to deliver the vaccine using the device called as CELLECTRA® which works by creating a pulse for transferring the plasmids across the cell. It is also developing INO 4700 in collaboration with GeneOne Life Sciences company [114]","divisions":[{"label":"td","span":{"begin":0,"end":22}},{"label":"td","span":{"begin":24,"end":363}}],"tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T183","span":{"begin":0,"end":124},"obj":"Sentence"},{"id":"T184","span":{"begin":125,"end":280},"obj":"Sentence"},{"id":"T185","span":{"begin":281,"end":370},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T183","pred":"source","obj":"LitCovid-sentences"},{"subj":"T184","pred":"source","obj":"LitCovid-sentences"},{"subj":"T185","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#93b1ec","default":true}]}]}}